Note 8 - Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Accrued Liabilities and Other Current Liabilities Disclosure [Text Block]

( 8 ) Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 31,
	2019		2018
Accrued expenses	$	10	$	127
Accrued salaries and employee benefits		652		368
Accrued director compensation		648		277
Accrued clinical trial costs		519		276
Grant liability		630		645
Customer deposits		102		112
Total	$	2,561	$	1,805